• Senolytic Effects of L. plantarum DS0037 Nanovesicles in Cel

  2026-05-19

  This study demonstrates that exosome-like nanovesicles derived from Lactobacillus plantarum DS0037 selectively induce apoptosis in senescent cells and modulate key gene expression linked to skin aging. The findings suggest a promising natural strategy for targeted anti-aging interventions and open avenues for functional cosmetic development.

• Optimizing iPSC-Derived Platelet Production: Functional Gain

  2026-05-19

  This study presents an optimized differentiation strategy for producing functional platelets from human induced pluripotent stem cells (hiPSCs). By refining culture conditions and incorporating small-molecule modulators, the protocol achieves higher yields, reduced costs, and improved platelet functionality—addressing major bottlenecks in scalable ex vivo platelet generation.

• Self-Assembling Virus-Mimetic Particles Enable Extrahepatic

  2026-05-18

  This study introduces a self-assembling, enveloped virus-mimicking particle (EVMP) platform designed for efficient and targeted delivery of mRNA to extrahepatic tissues, overcoming the hepatic bias of conventional lipid nanoparticle systems. By modular engineering of peptide and phospholipid components, the EVMP approach demonstrates high transfection efficiency, tissue specificity, and minimal immunogenicity, broadening the scope of mRNA therapeutics.

• Benzyl Quinolone Carboxylic Acid (BQCA): Reliable M1 Modulat

  2026-05-18

  This article examines how Benzyl Quinolone Carboxylic Acid (BQCA, SKU C3869) addresses reproducibility, sensitivity, and workflow challenges in cell viability and signaling assays. Drawing on recent mechanistic studies and practical lab scenarios, it guides researchers to leverage BQCA's selectivity and validated data for robust cognitive function and Alzheimer's disease research.

• Dabigatran Etexilate: Advancing Oral Anticoagulation Strateg

  2026-05-17

  This clinical review highlights dabigatran etexilate’s introduction as the first oral direct thrombin inhibitor, addressing key limitations of traditional anticoagulants for venous thromboembolism and atrial fibrillation. The study demonstrates dabigatran’s rapid, predictable pharmacology, reduced monitoring requirements, and its evolving place in therapy.

• 3-Aminobenzamide (PARP-IN-1): Precision PARP Inhibition in O

  2026-05-16

  Explore the advanced applications of 3-Aminobenzamide (PARP-IN-1) in dissecting poly (ADP-ribose) polymerase biology, with a focus on oxidant-induced dysfunction and emerging antiviral insights. This article reveals experimental strategies and mechanistic depth not found in standard protocol guides.

• WAY-100635: Precision Antagonism in Serotonin 5-HT1A Researc

  2026-05-15

  WAY-100635, a potent serotonin 5-HT1A receptor antagonist, enables high-specificity mapping of serotonergic pathways in both in vitro and in vivo models. Recent advances in pain research underscore its value for dissecting the interplay between cannabinoid and serotonin systems, with optimized workflows driving reproducibility in behavioral and neurochemical assays.

• SHC-1 Inhibition Regulates CFTR Membrane Abundance in Epithe

  2026-05-15

  This study reveals that SHC-1 inhibition modulates the plasma membrane abundance of the CFTR chloride channel via the MAPK pathway, with cell-type-specific effects observed across epithelial models. These findings refine mechanistic understanding of CFTR trafficking, informing research in cystic fibrosis, COPD, and secretory diarrhea.

• Dual Luciferase Reporter Gene System: Precision in Gene Regu

  2026-05-14

  Unlock high-sensitivity, dual-reporter gene expression assays with the Dual Luciferase Reporter Gene System from APExBIO. This system streamlines transcriptional regulation studies, offering robust normalization, rapid workflows, and advanced troubleshooting strategies for both plant and mammalian researchers.

• Applied Workflows with 3-(1-methylpyrrolidin-2-yl)pyridine (

  2026-05-14

  Leverage 3-(1-methylpyrrolidin-2-yl)pyridine (N2703) for precision modulation of cellular signaling pathways in advanced coculture and neuro-cardiac models. This guide delivers actionable workflow enhancements, troubleshooting strategies, and key insights from recent adipose-neural axis research for maximal experimental impact.

• EZ Cap™ Human PTEN mRNA (ψUTP): Enhancing Cancer Research Wo

  2026-05-13

  EZ Cap™ Human PTEN mRNA (ψUTP) enables researchers to efficiently restore tumor suppressor activity in advanced cancer models through robust, immune-evasive mRNA delivery. Its unique pseudouridine and Cap 1 modifications provide superior mRNA stability and translation efficiency, making it a standout tool for PI3K/Akt pathway inhibition and therapy resistance studies.

• EZ Cap™ Human PTEN mRNA (ψUTP): Precision Tool for Functiona

  2026-05-13

  Explore how EZ Cap™ Human PTEN mRNA (ψUTP) enables advanced, stable PTEN restoration for translational cancer research. This article highlights unique mechanistic insights, protocol optimization, and practical guidance beyond existing content.

• E-64d: Advancing Cysteine Protease Inhibition in Lysoptosis

  2026-05-12

  Explore how E-64d, a membrane-permeable cysteine protease inhibitor, enables next-generation study of lysoptosis, regulated cell death, and neuroprotection. This deep-dive reveals mechanistic insights, protocol best practices, and practical differentiation from prior approaches.

• Oseltamivir Acid: Influenza Neuraminidase Inhibitor in Resea

  2026-05-12

  Oseltamivir acid, the active metabolite of oseltamivir phosphate, is a gold-standard influenza neuraminidase inhibitor with validated workflows for antiviral and oncological research. Discover how its precise application, resistance management, and advanced assay integration drive both influenza and cancer studies beyond conventional approaches.

• Cefepime (BMY-28142): Optimizing CNS Infection Research Work

  2026-05-11

  Cefepime (BMY-28142) empowers researchers to model multidrug-resistant CNS infections with reliable blood-brain barrier penetration and broad-spectrum activity. This technical guide details experimental protocols, advanced use-cases, and troubleshooting tactics—anchored by recent epidemiological findings and APExBIO’s validated reagent supply.

638 records 15/43 page Previous Next First page 上5页 1112131415 下5页 Last page